Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cell Pathways to Present at UBS Warburg Global Life Sciences Conference.


Business Editors and Health/Medical Writers

UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Warburg Global Life Sciences Conference

BIOWIRE2K

HORSHAM, Penn.--(BUSINESS WIRE)--Oct. 3, 2002

Cell Pathways, Inc. (Nasdaq:CLPA CLPA CC-Link Partner Association
CLPA Club Loisirs et Plein Air (Montpellier, France)
CLPA Child Labour Programme of Action (national plan to eliminate child labour in South Africa) 
) announced today that Robert J. Towarnicki, the company's chairman and chief executive officer, will present an overview of the company's strategic plans and recent highlights at the UBS Warburg Global Life Sciences Conference at The Plaza Hotel The Plaza Hotel in New York City is a landmark 19-story luxury hotel with a height of 250 feet (76 m) and length of 400 feet that (122 m) occupies the west side of Grand Army Plaza, from which it derives its name, and extends along Central Park South in Manhattan.  in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
. Towarnicki's presentation will take place on Wednesday, October 9, 2002 at 1:30 p.m.

"We look forward to presenting Cell Pathways at UBS Warburg's widely-attended and prestigious life science conference and are glad to have the opportunity to present the company before the world's leading healthcare investors," stated Towarnicki.

The presentation will be available as a live webcast at www.ubswarburg.com. You can find the UBS Warburg conference link on the right hand side of the page. A replay will be available 3 hours after the actual presentation time and will be available until November 10, 2002.

About Cell Pathways

Cell Pathways, Inc., headquartered in Horsham, Penn., is a development stage pharmaceutical company focused on the research and development of novel and unique medications to treat and prevent cancer and to treat certain inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation
disease - an impairment of health or a condition of abnormal functioning

NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants;
. The company additionally markets and sells oncology-related products made by others. The company's initial drug candidates in clinical development are Aptosyn(R) (exisulind) and CP461. For additional information on Cell Pathways, Inc., visit the Company's web site at http://www.cellpathways.com.

Certain statements made herein, and oral statements made in respect hereof, constitute "forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such statements are those, which express plan, anticipation, intent, contingency or future development and/or otherwise are not statements of historical fact. These statements are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. These risks are detailed in the Company's reports filed from time to time under the Securities Act of 1933 and/or the Securities Exchange Act of 1934. You are encouraged to read these filings as they are made. They are available over the Internet from the SEC in its EDGAR Edgar or Eadgar (both: ĕd`gər), 943?–975, king of the English (959–75), son of Edmund, king of Wessex. In 957 the Mercians and Northumbrians rebelled against Edgar's brother Edwy and chose Edgar as their king.  database. Investors are cautioned not to place undue reliance on any such forward-looking statements, any of which may turn out to be wrong due to inaccurate assumptions, unknown risks, uncertainties or other factors. No forward-looking statement can be guaranteed; actual future results may vary materially. Both forward-looking statements and statements of historic fact must be understood in the context of the risks referred to above which characterize the Company's development stage business. The Company undertakes no obligation to update or revise the statements made herein or the factors, which may relate thereto there·to  
adv.
1. To that, this, or it.

2. Archaic In addition to that; furthermore.


thereto
Adverb

Formal

1. to that or it

2.
.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 3, 2002
Words:464
Previous Article:Fujitsu Technology Solutions Sees 750% ROI With salesforce.com; IT Infrastructure Company Maximizes Return on Software-Free CRM Investment.
Next Article:WorldPath Medicine Receives Financing for Expansion of International Physicians Network and Services; Opens Office in Gulf Region - Will Also Focus...
Topics:



Related Articles
Bone Care International Announces First Quarter Conference Call.
Andrx To Present At UBS Warburg 2002 Global Specialty Pharmaceuticals Conference.
Cell Pathways to Present at UBS Warburg Global Specialty Pharmaceuticals Conference.
Sonus Pharmaceuticals to Present at UBS Warburg Global Life Sciences Conference on October 8 in New York City.
Cell Pathways Announces Cost Reduction Measures and Emphasis on Completing Clinical Studies of Aptosyn - Exisulind - and CP461.
Ligand to Present at UBS Warburg Global Life Sciences Conference.
IDEXX Laboratories to Present at UBS Warburg Global Life Sciences Conference.
Cortex's CEO to Speak at Annual UBS Warburg Global Life Sciences Conference on September 22, 2003.
Curis to Present at UBS Global Life Science Conference.
BioSphere Medical, Inc. Presentation at the UBS Warburg Global Life Sciences Health Care Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles